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bstract
The replication of African swine fever virus DNA is initiated inside the nucleus of host cells, being followed by a longer cytoplasmic replication
tage. In face of previous results demonstrating the nucleo-cytoplasmic shuttling activity of ASFV p37 structural protein when considered isolated
rom the virus infection, we performed a systematic analysis of the subcellular localization of p37 protein in ASFV-infected cells, aiming at
dentifying the role of the nuclear transport mediated by this protein in the viral replication cycle. We report that the p37 protein of the incoming
irions is localized throughout the cell at early times post-infection, concentrated in distinct nuclear regions, while at later times the newly
ynthesized protein is detected exclusively in the cytoplasm of infected cells. Experiments using leptomycin B and siRNAs targeting the CRM1
eceptor demonstrate that the subcellular localization of p37 protein is not affected by inhibition of the CRM1-mediated nuclear export pathway.
inally, results from in situ hybridization experiments show a co-localization of the ASFV DNA and p37 protein in specific nuclear regions at early
imes post-infection, and in viral factories at later times. Overall, these results support the involvement of p37 protein in the nuclear transport of
he viral DNA during ASFV replication cycle.
2007 Elsevier B.V. All rights reserved.
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. Introduction
African swine sever virus (ASFV), the only member of
he new virus family Asfarviridae (Dixon et al., 2005), is the
ausative agent of a highly lethal hemorrhagic disease that
ffects domestic pigs (Vinuela, 1987).
The genome of the ASFV BA17V strain, a large lin-
ar double-stranded DNA molecule, has been completely
equenced and its analysis has identified 151 open-reading
rames, which encode approximately 50 structural proteins and
everal enzymes involved in viral DNA replication, gene tran-
cription and protein modification (Yanez et al., 1995). The
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nd Technology, University of Coimbra, Apartado 3126, 3001-401 Coimbra,
ortugal. Tel.: +351 239820190; fax: +351 239853607.
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oi:10.1016/j.virusres.2007.05.009RM1-independent nuclear export; Nuclear replication stage
SFV particles, which present an icosahedral shape and an
verage diameter of 200 nm (Almeida et al., 1967; Breese and
eBoer, 1966; Carrascosa et al., 1984; Schloer, 1985), are com-
osed of several concentric domains: an internal core consisting
f a central DNA-containing nucleoid coated by a thick protein
ayer similar to a matrix domain, referred to as core shell; an
nner lipid envelope, derived from the endoplasmic reticulum;
nd an icosahedral protein capsid (Andres et al., 1997, 1998).
he extracellular viral particles contain an additional lipid enve-
ope acquired in the process of budding through the plasma
embrane (Breese and DeBoer, 1966). ASFV resembles the
oxviruses in genome structure and gene expression strategy
Baroudy et al., 1983; Gonzalez et al., 1986; Moss, 1996; Salas
t al., 1999), while being morphologically similar to the iri-
oviruses (Carrascosa et al., 1984; Goorha and Granoff, 1994),
nd therefore has been described as a missing evolutionary link
etween the Poxviridae and Iridoviridae (Salas et al., 1999).
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Although initially it was reported that ASFV multiplied
xclusively in the cytoplasm of infected cells, evidence demon-
trating that the virus does not grow and no viral DNA synthesis
ccurs in enucleated Vero cells (Ortin and Vinuela, 1977) sug-
ested the involvement of the host cell nucleus in the process
f ASFV genome replication. Results from autoradiography
tudies of ASFV-infected macrophages, as well as from in
itu hybridization experiments performed in both macrophages
nd Vero cells, have demonstrated that virus-specific DNA
equences are localized inside the nucleus of cells at early times
f infection, suggesting that viral DNA synthesis is initiated
nside the nucleus, being followed by a longer replication stage
hat occurs in the cytoplasm (Garcia-Beato et al., 1992; Rojo et
l., 1999).
Analysis of the replicative intermediates that are synthesized
n the nucleus and cytoplasm of ASFV-infected cells has shown
hat small DNA fragments are synthesized in the nucleus at early
imes of viral DNA replication, whereas large molecules are
ynthesized in the cytoplasm at later times. Based on these obser-
ations, a de novo start mechanism of ASFV DNA replication,
imilar to the model of Baroudy et al. (1983) for the vaccinia
irus DNA replication, has been proposed (Rojo et al., 1999).
Although ASFV DNA replication has been described to occur
n two distinct subcellular compartments (nucleus and cyto-
lasm), no information exists on the mechanisms by which the
SFV DNA is transported between the nucleus and the cyto-
lasm of infected cells. Most likely, this transport occurs through
he nuclear pore complex and is mediated by cellular and/or
iral proteins, similarly to what has been described for other
iruses (reviewed in Whittaker and Helenius, 1998; Whittaker
t al., 2000; Whittaker, 2003; Greber and Fassati, 2003;
reber and Fornerod, 2004; Bukrinsky, 2005). In this context,
he identification and characterization of ASFV proteins that
xhibit nucleo-cytoplasmic transport activity are of particular
nterest.
Recently, we have described p37 protein, a product of the
roteolytic processing of the polyprotein pp220 (Simon-Mateo
t al., 1993), as the first nucleo-cytoplasmic shuttling protein
ncoded by ASFV (Eulalio et al., 2004). Additionally, we have
emonstrated that the nuclear export of ASFV p37 protein in
ero cells, when studied isolated from the virus infection, is
very efficient process, which occurs both by the CRM1-
ependent and a CRM1-independent nuclear export pathways
Eulalio et al., 2006).
In the present study we show that the ASFV p37 protein of the
ncoming virus is localized in distinct nuclear regions of Vero
ells at early stages of infection, whereas at later times post-
nfection the newly synthesized protein is localized exclusively
n the cytoplasm, concentrated in the viral factories. Addition-
lly, we demonstrate that inhibition of the CRM1 nuclear export
athway has no effect on the subcellular localization of p37 pro-
ein in ASFV-infected cells, as well as on the kinetics of viral
eplication. Finally, immunofluorescence and in situ hybridiza-
ion experiments on the subcellular localization of p37 protein
nd ASFV DNA demonstrate a clear co-localization of p37 and
NA in nuclear foci at early times post-infection, as well as
n the viral factories at late stages of infection. Overall, these
(
A
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esults are consistent with a role for p37 protein in the nuclear
ransport of viral DNA during the viral replication cycle.
. Materials and methods
.1. Cell culture and virus
Vero cells were grown and maintained in Dulbecco’s mod-
fied Eagle’s medium—high glucose (DMEM-HG) (Sigma),
upplemented with 10% (v/v) heat-inactivated fetal bovine
erum (FBS) (Biochrom KG) and with 100 U of penicillin and
00g of streptomycin (Sigma) per ml, in a 5% CO2 humidified
tmosphere, at 37 ◦C.
The ASFV BA71V strain, adapted to grow in Vero cells, has
lready been described (Enjuanes et al., 1976). Highly purified
A71V virus was obtained by Percoll equilibrium centrifugation
Carrascosa et al., 1985).
.2. Anti-p37 antibody
The antibody against ASFV p37 protein used in the
mmunofluorescence studies was obtained from rabbits immu-
ized with the synthetic peptide NLTHNKQEFQSYEENY,
hich corresponds to amino acids 39–54 of this protein. The
ntibody was purified by affinity chromatography (Eurogentec),
nd the specificity of the purified antibody was characterized
y Western-blot and immunofluorescence analysis in ASFV-
nfected Vero cells.
.3. Western-blot analysis
For Western-blot analysis, Vero cells were either mock-
nfected or infected with ASFV, and 24 h post-infection the cells
ere lysed in electrophoresis sample buffer (62.5 mM Tris–HCl,
H 6.8, 2% SDS, 5% -mercaptoethanol, 10% glycerol, and
.01% bromophenol blue). After brief sonication, the samples
ere heated to 95 ◦C for 10 min. Equivalent protein amounts
f the cell lysates, as well as 1g of purified ASFV parti-
les, were separated on a 10% SDS-PAGE gel and the resolved
roteins were transferred onto nitrocellulose membranes (Amer-
ham Biosciences). The blot was blocked with 5% (w/v) dry
ilk in Tris-buffered saline plus Tween (TBST), and then incu-
ated with the anti-p37 antibody or with the mouse monoclonal
nti-actin antibody (Sigma) in TBST containing 1% dry milk
owder. After washing three times with TBST, the membrane
as incubated with peroxidase-conjugated secondary antibodies
Amersham Life Sciences). The blots were revealed by electro-
hemiluminescence (ECL System, Amersham Life Sciences),
ccording to the manufacturer’s instructions.
.4. Immunofluorescence analysis
Preconfluent cultures of Vero cells, grown in glass coverslips
13 mm diameter), were either mock-infected or infected with
SFV, at a multiplicity of infection of 40 pfu/cell for immunoflu-
rescence analysis at 0, 2, 4, 6 and 8 hpi, or with 10 pfu/cell for
he immunofluorescence analysis at 14 and 18 hpi. To synchro-
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ize the infection process, adsorption of ASFV to the cells was
erformed for 2 h at 4 ◦C, in DMEM-HG supplemented with
% (v/v) FBS and 25 mM HEPES, pH 7.4, with gentle stirring.
ollowing adsorption, the cells were washed thoroughly with
MEM-HG supplemented with 2% (v/v) FBS, and the infection
as allowed to progress at 37 ◦C, for the indicated times. Paral-
el experiments were performed in the presence of 50g/ml of
ytosine arabinoside (AraC). Following the indicated incubation
eriods, mock-infected and ASFV-infected cells were washed
ith PBS and fixed with 4% paraformaldehyde for 15 min, fol-
owed by 5 min incubation in methanol at −20 ◦C. The cells were
hen permeabilized with 0.2% Triton X-100 in PBS for 5 min
t room temperature, blocked with 3% bovine serum albumin
BSA) in PBS at room temperature for 30 min, and incubated
or 1 h at room temperature with the anti-p37 antibody and the
nti--tubulin monoclonal antibody (Sigma), in blocking solu-
ion. After extensive washing with PBS, the cells were incubated
or 1 h, at room temperature, with Alexa Fluor 488 goat anti-
abbit IgG and Alexa Fluor 594 goat anti-mouse IgG antibodies
Molecular Probes), diluted in blocking solution. The cells were
urther washed and the coverslips were mounted onto glass slides
sing Mowiol (Calbiochem).
Fluorescence observations were performed using a BIORAD
adiance 2000 laser scanning fluorescence confocal micro-
cope, at a 600× magnification.
.5. Leptomycin B treatment and CRM1 silencing
xperiments
Preconfluent monolayers of Vero cells, seeded in 24 well
lates (wells of 2 cm2) and pre-treated or not with 20 ng/ml of
eptomycin B (LMB) for 1 h, were infected with ASFV BA71V
train, at a multiplicity of infection of 10 pfu/cell (for virus
itration experiments) or 40 pfu/cell (for immunofluorescence
xperiments) in DMEM supplemented with 2% (v/v) FBS, in
he presence or not of LMB (20 ng/ml). After 2 h of adsorption,
he inoculum was removed and the cells were washed with fresh
MEM and further incubated, in DMEM supplemented with
% FBS containing or not LMB (20 ng/ml), for the indicated
imes.
The short interfering RNA duplex used for depletion of
RM1 receptor (CRM1 siRNA) (sense UGUGGUGAAU-
GCUUAUACd(TT); anti-sense GUAUAAGCAAUUCAC-
ACAd(TT)) (Lund et al., 2004), targeted to the residues
0–108 of the human CRM1 receptor, was obtained from Qia-
en. Twenty-four hours prior to infection of cells with ASFV
A71V strain, preconfluent monolayers of Vero cells were
ransfected with the siRNAs using Lipofectamine 2000 (Invit-
ogen), according to the manufacturer’s instructions. Reduction
f the expression levels of the CRM1 receptor was confirmed
y Western-blot in parallel experiments (data not shown), as
escribed previously (Eulalio et al., 2006)..6. Plaque assays
The cells infected with ASFV BA71V strain and their culture
upernatants, under the different experimental conditions, were
t
i
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arvested at different times post-infection, sonicated and titrated
y plaque assay (Enjuanes et al., 1976).
.7. In situ hybridization with ASFV-specific
igoxigenin-labeled DNA probes
Total viral DNA isolated from purified virions was used as a
robe to detect ASFV DNA in the in situ hybridization exper-
ments, as previously reported (Garcia-Beato et al., 1992). The
NA probe was labeled with digoxigenin-11-dUTP, according
o the manufacturer’s instructions (Roche Applied Science).
The procedure for the in situ hybridization experiments using
igoxigenin-labeled probes has been previously described by
arcia-Beato et al. (1992). Briefly, mock-infected and ASFV-
nfected Vero cells cultured in activated coverslips were fixed at
istinct times post-infection with a solution of ethanol:acetic
cid (3:1). After digestion with proteinase K (1g/ml) for
5 min at 37 ◦C, the samples were treated with 100g/ml of
NAse A and 10 U/ml RNAse T1 for 30 min at 37 ◦C. The
NA was denatured by incubating the samples in a solution
ontaining 95% freshly deionized formamide and 0.1× SSC at
5 ◦C for 15 min. Prehybridization was then performed by incu-
ation of the samples for 15 min at 42 ◦C in 45% formamide, 6×
SC, 5× Denhardt’s solution and 100g/ml denatured salmon
perm DNA. For the hybridization step, the cell samples were
ncubated overnight in 45% formamide, 6× SSC, 5× Den-
ardt’s solution and 10% dextran sulphate containing 10 ng of
enaturated ASFV DNA probe under siliconized coverslips, at
2 ◦C in a humidified chamber. Following the hybridization step,
he samples were washed thoroughly with 2× SSC at room
emperature, followed by permeabilization with 0.2% Triton
-100 in PBS. After extensive washing with PBS, the sam-
les were then incubated with 50g/ml sheep anti-digoxigenin
ab fragments conjugated with fluorescein (Roche Applied Sci-
nce) in PBS containing 0.5% BSA and 1% blocking reagent
Roche Applied Science), for 1 h at room temperature. The sam-
les were then processed for immunofluorescence as described
bove, and labeled with anti-p37 and anti--tubulin antibodies,
ecognized, respectively by Alexa Fluor 594 goat anti-rabbit
gG and Alexa Fluor 647 goat anti-mouse IgG (Molecular
robes).
. Results
.1. ASFV p37 protein is localized in distinct subcellular
ompartments during viral infection
To examine the subcellular localization of p37 protein during
he process of infection by ASFV, immunofluorescence studies
ere performed using a new antibody raised against ASFV p37
rotein (amino acids 39 to 54; Section 2.2). The specificity of
his antibody was demonstrated by Western-blot analysis, which
howed that the anti-p37 antibody does not recognize any pro-
ein in the extract from non-infected cells (mock cells), whereas
n the extract from ASFV-infected cells the antibody recognizes
SFV p37 protein (Fig. 1). As expected, the antibody also rec-
gnizes the precursors of p37 protein, namely the immediate
A. Eula´lio et al. / Virus Resea
Fig. 1. Western-blot analysis of the specificity of the anti-p37 antibody. Equiv-
alent protein amounts of lysates of mock-infected or ASFV-infected Vero cells,
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ASFV proteins. These results demonstrate that the p37 proteins well as 1g of purified ASFV particles were separated by SDS-PAGE and
nalyzed by Western-blot using an anti-p37 antibody obtained as described in
ection 2.2. Reprobing with anti-actin antibody was performed as control.
olyprotein precursor pp55 (which originates p14 and p37), the
olyprotein precursor pp90 (which originates pp55 and p34),
nd finally the pp220 polyprotein. In purified virus particles the
ntibody only recognized the p37 protein, in agreement with
bservations demonstrating that only the final and correctly pro-
essed products of polyprotein precursor pp220 are incorporated
nto virus particles (Simon-Mateo et al., 1993) (Fig. 1).
As shown in Fig. 2, p37 protein was not detected by
mmunofluorescence in ASFV-infected Vero cells at very early
imes post-infection (0 and 2 hpi), most likely because the anti-
ody has no access to the protein localized in the inner core
hell domain of the incoming virus particles (Andres et al.,
997, 2002a,b). The p37 protein was first detected at 4 hpi,
eing found both in the cytoplasm and nucleus, accumulating
n specific nuclear regions. At 6 hpi, p37 protein accumulation
n distinct regions inside the nucleus of infected Vero cells was
onsiderably more pronounced than at earlier times, although
d
o
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he protein continued to be detected throughout the cytoplasm
f the infected cells.
Interestingly, at later times of the infection cycle, namely
hpi, the nuclear signal of p37 protein was considerably weaker,
he protein being localized mainly in the cytoplasm of the
nfected cells in a diffuse pattern (Fig. 2).
At 14 and 18 hpi, the p37 protein was concentrated in the viral
actories, although fluorescence was also detected throughout
he cytoplasm (Fig. 2). The signal detected at the viral factory
ost likely corresponds to the newly synthesized p37 protein
nd its precursor, which are induced at these late times of the
nfection cycle and are known to localize at the virus assembly
ites (Andres et al., 1997).
Representative images from immunofluorescence experi-
ents in mock-infected cells (at 14 hpi), which were performed
s a control to demonstrate the specificity of the anti-p37 anti-
ody, are shown for comparison. The subcellular localization
f -tubulin was simultaneously determined to facilitate the
nalysis of the localization of the p37 protein.
The presence of the p37 protein inside the nucleus at the initial
tages of the infection cycle, followed by its disappearance from
his compartment at later times, may suggest a role of this protein
elated to the nuclear phase of viral DNA replication.
.2. ASFV p37 protein detected at early times of infection
riginates from infecting ASFV particles, rather than from
e novo protein synthesis
It is well documented that ASFV pp220 polyprotein and, con-
equently all the products of its proteolytic processing including
37 protein, are late viral proteins (Andres et al., 1993; Simon-
ateo et al., 1993), whose synthesis is initiated only after viral
NA replication. This finding suggests per se that the p37 pro-
ein that is detectable by immunofluorescence at early times of
nfection is that derived from incoming ASFV particles, which
re responsible for cell infection.
To clarify this issue, immunofluorescence experiments on the
ubcellular localization of p37 protein were performed in ASFV-
nfected Vero cells following treatment with AraC, a drug that
locks the activity of cellular and viral DNA polymerases, thus
nhibiting viral DNA replication and consequently the synthesis
f late ASFV proteins, including the polyprotein pp220 (Andres
t al., 1993).
In ASFV-infected and AraC-treated cells, p37 protein pre-
ented the same subcellular localization as in infected and
on-treated cells, being localized in specific nuclear regions and
n the cytoplasm at 6 hpi, and absent from the nucleus at interme-
iate times of infection (8 hpi) (compare Fig. 3 with Fig. 2). As
xpected, no p37 protein was detected at late times post-infection
14 hpi) in ASFV-infected and AraC-treated cells (Fig. 3), since
ell treatment with AraC indirectly impairs the synthesis of lateetected by immunofluorescence at early and intermediate times
f infection (6 and 8 hpi) is the protein that entered into Vero cells
ncorporated in the infecting virus particles, rather than newly
ynthesized protein.
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rocessed for immunofluorescence analysis at the indicated times post-infection
y incubation with secondary antibodies conjugated to Alexa 488 and 594, respe
icroscopy images are shown.
.3. The subcellular localization of p37 protein in
SFV-infected cells is not affected by inhibition of the
RM1-dependent nuclear export pathway
We have previously reported that the nuclear export of p37
rotein in Vero cells is a very efficient process that occurs
hrough two distinct pathways: the CRM1-dependent and an
nidentified CRM1-independent pathway (Eulalio et al., 2006).
oreover, we have demonstrated that the nuclear export of
ull-length p37 protein is partially inhibited by both specific
epletion of the CRM1 receptor by RNA interference and lepto-
ycin B, a metabolite that potently and specifically blocks the
RM1-dependent nuclear export pathway by binding directly
o a cysteine residue of the CRM1 receptor (Eulalio et al.,
006).
In this context, aiming at investigating the contribution of the
RM1-dependent pathway to the nuclear export of p37 protein
n ASFV-infected Vero cells, the subcellular localization of p37
rotein was analysed at different times post-infection, in cells
n which this nuclear export pathway was specifically inhib-
ted either by leptomycin B or siRNAs targeted to the CRM1
eceptor.At early times of infection (4 and 6 hpi), there was no change
n p37 protein localization in infected cells that were either
reated with LMB or transfected with siRNAs targeted to the
RM1 receptor, the protein being located in the nucleus and
t
d
o
ces post-infection. Vero cells infected with ASFV BA71V strain were fixed and
ples were incubated with antibodies against p37 protein and -tubulin, followed
ly. Experiments were performed at least three times and representative confocal
ytoplasm similarly to what was observed in non-treated cells
compare Fig. 4 with Fig. 2). Accordingly, at intermediate and
ate times of infection (8 and 14 hpi) no nuclear accumulation
f p37 protein was detected upon inhibition of the CRM1-
ependent pathway by either of the two referred experimental
pproaches, the protein remaining localized exclusively in the
ytoplasm of the ASFV-infected cells (Fig. 4).
Overall, these results clearly show that, in ASFV-infected
ells, no significant differences are observed in the subcellular
ocalization of p37 protein upon inhibition of the CRM1-
ediated nuclear export pathway.
.4. Inhibition of the CRM1-mediated nuclear export
athway has no effect on the kinetics of ASFV replication in
ero cells
Although no significant differences in the subcellular local-
zation of p37 protein were observed in ASFV-infected cells
pon inhibition of the CRM1-dependent nuclear export path-
ay, experiments were performed to evaluate the relevance of
his pathway to the kinetics of viral replication. For this pur-
ose, the growth of the ASFV BA71V strain, which was used
hroughout this study, was examined in cells in which the CRM1-
ependent pathway was inhibited either by treatment with LMB
r depletion of the CRM1 receptor using a specific siRNA, and
ompared to that observed in non-treated cells.
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Fig. 3. Subcellular localization of p37 protein in ASFV-infected cells following treatment with AraC. Vero cells were infected with ASFV BA71V strain and incubated
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xperiments were performed at least three times and representative confocal m
As can be inferred from the one-step growth curves obtained
nder the different experimental conditions, no significant differ-
nces were observed in the yield of virus produced in the cells in
hich the CRM1-mediated nuclear export pathway was inhib-
ted, when compared to that obtained in control (non-treated)
ells infected with the BA71V virus (Fig. 5).
Overall, these results demonstrate that, independently of the
trategy used to inhibit the nuclear export mediated by the CRM1
eceptor (LMB treatment or RNA interference), the inhibition
f this nuclear export pathway has no significant effect on the
inetics of ASFV replication in Vero cells.
.5. p37 protein and ASFV DNA co-localize in the nucleus
f infected Vero cells at early times post-infectionPrevious studies have shown that specific ASFV DNA
equences are present in the nucleus of infected Vero cells at
arly times of infection, accumulating in dense foci localized
f
t
t
tNA replication and consequently the synthesis of late ASFV proteins. Samples
tion with secondary antibodies conjugated to Alexa 488 and 594, respectively.
opy images are shown (magnification 600×).
n the vicinity of the nuclear membrane, whereas at later stages
f infection, the viral DNA is localized exclusively in the cyto-
lasm, concentrated in the viral factories (Garcia-Beato et al.,
992).
To determine whether, at early stages of viral infection, the
pecific nuclear regions of p37 protein accumulation correspond
o the foci where the viral DNA is present, the subcellular
ocalization of p37 protein and viral DNA was simultaneously
etermined by immunofluorescence and in situ hybridization
xperiments in Vero cells. To facilitate the analysis, immunoflu-
rescence labelling of the cytoplasmic marker -tubulin was
lso performed.
As can be observed in Fig. 6, in situhybridization experiments
howed that, at 6 hpi, the ASFV DNA is concentrated in distinct
oci inside the nucleus. As previously shown, at 6 hpi, p37 pro-
ein is also localized in distinct nuclear regions. Remarkably,
he merged confocal images demonstrate that p37 protein and
he ASFV DNA are co-localized in these distinct foci. Further-
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Fig. 4. Effect of leptomycin B treatment or depletion of the CRM1 receptor by RNA interference on the subcellular localization of p37 protein in ASFV-infected
cells. Vero cells were either pre-treated with 20 ng/ml of leptomycin B for 2 h and then infected and further incubated in the presence of the same concentration of
the drug (+LMB), or transfected with siRNAs for CRM1 depletion 24 h prior to infection (+CRM1 siRNA). At the indicated times post-infection, Vero cells were
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ndoubtedly confirms that those foci are localized inside the
ucleus.
At intermediate times post-infection (8 hpi), both the ASFV
NA and p37 protein are absent from the nucleus, being detected
xclusively in the cytoplasm of the infected cells, concentrated
n regions that are most likely precursors of the viral factories
Fig. 6). At later times (14 hpi), the overlaid confocal images
how an evident co-localization of the ASFV DNA and p37 pro-
ein, or its polyprotein precursors, in the viral factories (Fig. 6).
Control experiments with mock-infected cells show a low
on-specific background staining of the cytoplasm, but not
nside the nucleus, confirming the specificity of the hybridization
ignal detected in ASFV-infected cells.
It should be noted that due to the experimental procedure
sed in the in situ hybridization studies, which involves treat-
ent of cells with proteinase K to allow the accessibility of theigoxigenin-labeled DNA probe to the viral DNA, the signal
orresponding to p37 protein was weaker than that obtained in
he immunofluorescence experiments described in the previous
ections.
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rith antibodies against p37 protein and -tubulin, followed by incubation with
e performed at least three times and representative confocal microscopy images
The co-localization of the viral DNA and p37 protein in dis-
inct nuclear regions at the initial stages of the infection cycle
nd their simultaneous disappearance from the nucleus at later
imes are consistent with the involvement of p37 protein in the
ucleo-cytoplasmic transport of the ASFV DNA.
. Discussion
Many viruses have a nuclear replication stage or replicate
xclusively inside the nucleus of their host cells, and therefore
he nucleo-cytoplasmic transport of viral components plays a
entral role in their replication cycle. With the exception of a
ew viruses, the transport across the nuclear envelope during
iral replication occurs through the nuclear pore complex and
xploits the host cellular machinery, in particular the nuclear
mport and export receptors and transport factors (Whittaker and
elenius, 1998; Whittaker et al., 2000; Whittaker, 2003; Grebernd Fassati, 2003; Greber and Fornerod, 2004; Bukrinsky, 2005).
In this context, the existence of an initial phase of ASFV
enome replication inside the nucleus, followed by a longer
eplication stage in the cytoplasm (Garcia-Beato et al., 1992;
A. Eula´lio et al. / Virus Resea
Fig. 5. One-step growth curves of BA71V virus produced in the presence of
leptomycin B or in CRM1-depleted Vero cells. Infection with ASFV BA71V
strain (10 pfu/cell) was performed in: (i) non-treated Vero cells (control); (ii)
Vero cells treated with 20 ng/ml of leptomycin B (+LMB); or (iii) Vero cells
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transfected with siRNAs for CRM1 depletion 24 h prior to infection (+CRM1
iRNA). At different times post-infection, the samples were collected and titrated
y plaque assay on Vero cells.
ojo et al., 1999), strongly suggests that some viral proteins,
ogether with the viral DNA, are actively transported between
he nucleus and cytoplasm of host cells.
Following previous studies in our laboratory demonstrating
hat p37 protein, when studied isolated from the virus infection,
s actively transported between the nucleus and the cytoplasm
f Vero cells (Eulalio et al., 2004), the evaluation of the nucleo-
ytoplasmic transport activity of this protein during ASFV
nfection was considered pertinent.
The results presented here show that p37 protein is present in
istinct subcellular compartments at different times of the infec-
ion cycle. At early times post-infection, the protein is present
n the cytoplasm and nucleus of Vero cells, particularly con-
entrated in distinct nuclear regions, whereas at later times the
37 protein is absent from the nucleus, being detected exclu-
ively in the cytoplasm of virus-infected cells. Results obtained
rom experiments performed in ASFV-infected cells in which
ate gene expression was inhibited demonstrate that the p37 pro-
ein detected at early times post-infection is the structural p37
rotein of the incoming virus particles, which is thus able to
nter the nucleus at these times.
On the other hand, the protein detected in viral factories at
ate times post-infection corresponds to newly synthesized p37
rotein, and/or its polyprotein precursors. Since p37 protein is
ocalized in the viral core shell, a matrix-like domain that sur-
ounds the DNA-containing nucleoid of the virus (Andres et al.,
997, 2002a,b), a likely explanation for the fact that p37 pro-
ein has not been detected at very early times post-infection,
amely at 0 and 2 hpi, is that the anti-p37 antibody access to p37
rotein in the viral particle has been hampered, even following
ell permeabilization. According to this hypothesis, the antibody
ould only have access to p37 protein after the disassembly of
irus particles, particularly the capsid breakdown, which would
xplain the detection of the protein only at 4 h post-infection.
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he observation that, in contrast to p37 protein, the p72 ASFV
rotein is detected by immunofluorescence at very early times
ost-infection (data not shown) also supports this hypothesis
ince p72 protein is the major capsid component.
The fate of the nuclear p37 protein is not clear at present.
ur previous results have demonstrated that the nuclear export
f p37 protein is very efficient, comparable to the nuclear export
ediated by the nuclear export signals (NES) present in HIV-1
ev protein. Furthermore, it was shown that p37 protein nuclear
xport is mediated by three NESs and occurs through two dis-
inct nuclear export pathways, the CRM1-dependent and an
nidentified CRM1-independent pathway (Eulalio et al., 2006).
ince the nuclear export of p37 protein mediated by a CRM1-
ndependent pathway has a strength comparable to that mediated
y the CRM1-dependent pathway (Eulalio et al., 2006), it is
ossible that, in the context of full-length p37 protein and par-
icularly during the ASFV infection, the protein will be able to
xit the nucleus even when the CRM1-dependent route is inhib-
ted, by using a CRMI-independent pathway. This would explain
he results obtained from the immunofluorescence experiments
ith cells infected in the presence of leptomycin B, in which the
ubcellular localization of p37 is the same as that observed in
on-treated cells.
Given the large size of the ASFV genome, a linear double-
tranded DNA molecule of 170–190 kbp depending on the virus
solate (Blasco et al., 1989), it is clear that the viral DNA can only
nter into the nucleus by an active transport process. Likewise,
he exit of the replicating viral DNA, as well as of the replicative
ntermediates, from the nucleus is most likely a very complex
rocess. By analogy to other viruses, it can be speculated that
he ASFV DNA is transported into the nucleus of infected cells
s a complex with viral, and perhaps, cellular proteins, rather
han in an isolated form.
Previous results from in situ hybridization experiments in
SFV-infected Vero cells have demonstrated that, at early times
f infection, the viral DNA is localized in distinct nuclear regions
Garcia-Beato et al., 1992). In this context, the observation
eported in the present study of a similar pattern of localiza-
ion for p37 protein prompted us to perform studies aimed at
imultaneously determine the subcellular localization of the p37
rotein and viral DNA. Remarkably, our results show a perfect
o-localization of the ASFV DNA and p37 protein in specific
uclear regions, at early times post-infection, whereas at later
imes of infection both of them are localized in the cytoplasm,
oncentrated in the viral factories.
These observations indicate that during the early nuclear
tage of ASFV genome replication at least one viral protein is
resent in the subnuclear region where the viral DNA is local-
zed, reinforcing the importance of investigating the early steps
f the viral replication cycle.
Presently, the requirement of the nucleus for ASFV DNA
eplication is not clear. Although it has been demonstrated that
he virus encodes most of the proteins required for its genome
eplication, namely a DNA polymerase (Rodriguez et al., 1993),
homologue of the proliferating cell nuclear antigen (PCNA)
Yanez et al., 1995), a DNA ligase (Yanez and Vinuela, 1993),
type II topoisomerase (Baylis et al., 1992; Garcia-Beato et al.,
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Fig. 6. Simultaneous evaluation of the subcellular localization of ASFV DNA and p37 protein in ASFV-infected cells, at different times post-infection. Mock-infected
and ASFV-infected Vero cells were fixed and processed for simultaneous in situ hybridization and immunofluorescence analysis, at the indicated times post-infection.
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992) and several DNA helicases (Baylis et al., 1993; Yanez et
l., 1993, 1995), the existence of a nuclear stage of replication
as been attributed to a requirement for cellular proteins in the
nitiation of the viral DNA synthesis. Supporting this hypothesis,
xperiments in ASFV-infected cells treated with aphidicolin, an
nhibitor of the cellular DNA polymerases  and  but with
o effect on the viral DNA polymerase, suggest that a cellular
NA polymerase may be involved in early steps of ASFV DNAeplication (Marques and Costa, 1992).
The results described in the present report showing that the
tructural p37 protein of the infecting ASFV is in close associ-
tion with the viral DNA during the early steps of viral DNA
l
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pe was detected with an anti-digoxigenin antibody conjugated with fluorescein.
tibodies, which were detected with secondary antibodies conjugated to Alexa
sentative confocal microscopy images are shown (magnification 600×).
eplication, which occur in the nucleus, suggest that this pro-
ein accompanies the viral DNA during its transport into the
ucleus, which may facilitate the entry of the virus genome into
his compartment to initiate replication. This is the first viral
rotein identified as forming part of the nuclear foci where the
iral DNA is localized. In an alternative or complementary sce-
ario, p37 protein could also be involved in the export of the viral
enome from the nucleus to the cytoplasm of infected cells, fol-
owing the brief nuclear replication phase. Most likely, other
iral proteins are also involved in this process. Among others,
SFV p14 protein, a structural ASFV protein which is also a
roduct of the proteolytic processing of the polyprotein precur-
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or pp220, has been demonstrated to be actively imported into
he cell nucleus (Eulalio et al., 2004), thus constituting another
andidate to mediate the nuclear import of the ASFV genome.
It is clear that further studies are needed to characterize in
etail the mechanisms of the nucleo-cytoplasmic transport of
he ASFV genome. However, our observations of the distinct
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iral infection cycle, which might be explained by the previously
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